Evidence map›Paper›PMID 37212653›Full record

ArticleAntimicrobial agents and chemotherapy2023

Contribution of Iron-Transport Systems and β-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.

Habtamu Asrat, Jevon Samaroo-Campbell, Subhan Ata, John Quale

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Siderophore cephalosporins.EcoSal Plus · 2025
    Review
  4. Article
  5. Article
  6. Antimicrobial agents and chemotherapy · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Antimicrobial agents and chemotherapy · 2023
    Article
  11. Review
  12. Genomics ofMicrobial genomics · 2023
    Article
  13. Characteristics of a Carbapenem-ResistantInfection and drug resistance · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Habtamu AsratDivision of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Jevon Samaroo-CampbellDivision of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Subhan AtaDivision of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, USA.
John QualeDivision of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, USA.ORCID 0000-0001-6043-4298
SUNY Downstate Health Sciences University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of resistance to cefiderocol among multidrug resistant Acinetobacter baumannii has been attributed to downregulation in iron transport systems and a variety of β-lactamases. However, the precise contribution of each in clinical isolates remains to be determined. Sixteen clinical isolates with varying degrees of cefiderocol resistance were investigated. Susceptibility testing was performed with and without the presence of iron and avibactam. Expression of 10 iron transport systems and

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsAzabicyclo Compoundsbeta-LactamasesCefiderocolCephalosporinsDrug Resistance, Multiple, BacterialIronMicrobial Sensitivity TestsMitomycinNew York CityAnti-Bacterial AgentsavibactamAzabicyclo Compoundsbeta-LactamasesCefiderocolCephalosporinsIronMitomycincefiderocolsiderophores

Identifiers

PMID37212653
PMCPMC10269113
OpenAlexW4377220211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.